Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone Acetylation

被引:25
作者
Mossman, David [1 ,2 ]
Scott, Rodney J. [1 ,2 ,3 ]
机构
[1] Univ Newcastle, Discipline Med Genet, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] John Hunter Hosp, Div Genet, Hunter Area Pathol Serv, Newcastle, NSW, Australia
关键词
EARLY EVENT; PROMOTER METHYLATION; ABERRANT METHYLATION; BINDING; DEMETHYLATION; PROGNOSIS; BIOMARKER;
D O I
10.1371/journal.pone.0023127
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epigenetic regulation of genes involves the coordination of DNA methylation and histone modifications to maintain transcriptional status. These two features are frequently disrupted in malignancy such that critical genes succumb to inactivation. 5-aza-2'-deoxycytidine (5-aza-dC) is an agent which inhibits DNA methyltransferase, and holds great potential as a treatment for cancer, yet the extent of its effectiveness varies greatly between tumour types. Previous evidence suggests expression status after 5-aza-dC exposure cannot be explained by the DNA methylation status alone. Aim: We sought to identify chromatin changes involved with short and long term gene reactivation following 5-aza-dC exposure. Two colorectal cancer cell lines, HCT116 and SW480, were treated with 5-aza-dC and then grown in drug-free media to allow DNA re-methylation. DNA methylation and chromatin modifications were assessed with bisulfite sequencing and Chromatin Immuno-Precipitation analysis. Results: Increased H3 acetylation, H3K4 tri-methylation and loss of H3K27 tri-methylation were associated with reactivation. Hypermethylated genes that did not show increased acetylation were transiently expressed with 5-aza-dC treatment before reverting to an inactive state. Three reactivated genes, CDO1, HSPC105 and MAGEA3, were still expressed 10 days post 5-aza-dC treatment and displayed localised hypomethylation at the transcriptional start site, and also an increased enrichment of histone H3 acetylation. Conclusions: These observations suggest that hypomethylation alone is insufficient to reactivate silenced genes and that increased Histone H3 acetylation in unison with localised hypomethylation allows long term reversion of these epigenetically silenced genes. This study suggests that combined DNA methyltransferase and histone deacetylase inhibitors may aid long term reactivation of silenced genes.
引用
收藏
页数:9
相关论文
共 39 条
[1]  
[Anonymous], LEUK RES
[2]  
[Anonymous], CARCINOGENESIS
[3]  
[Anonymous], J REPROD DEV
[4]  
Aparicio Ana, 2002, Curr Opin Investig Drugs, V3, P627
[5]   Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer [J].
Baba, Yoshifumi ;
Nosho, Katsuhiko ;
Shima, Kaori ;
Freed, Ellen ;
Irahara, Natsumi ;
Philips, Juliet ;
Meyerhardt, Jeffrey A. ;
Hornick, Jason L. ;
Shivdasani, Ramesh A. ;
Fuchs, Charles S. ;
Ogino, Shuji .
CLINICAL CANCER RESEARCH, 2009, 15 (14) :4665-4673
[6]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[7]   A bivalent chromatin structure marks key developmental genes in embryonic stem cells [J].
Bernstein, BE ;
Mikkelsen, TS ;
Xie, XH ;
Kamal, M ;
Huebert, DJ ;
Cuff, J ;
Fry, B ;
Meissner, A ;
Wernig, M ;
Plath, K ;
Jaenisch, R ;
Wagschal, A ;
Feil, R ;
Schreiber, SL ;
Lander, ES .
CELL, 2006, 125 (02) :315-326
[8]   Unique Methylation Pattern of Oncostatin M Receptor Gene in Cancers of Colorectum and Other Digestive Organs [J].
Deng, Guoren ;
Kakar, Sanjay ;
Okudiara, Keisuke ;
Choi, Esther ;
Sleisenger, Marvin H. ;
Kim, Young S. .
CLINICAL CANCER RESEARCH, 2009, 15 (05) :1519-1526
[9]   CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients [J].
Dietrich, Dimo ;
Krispin, Manuel ;
Dietrich, Joern ;
Fassbender, Anne ;
Lewin, Joern ;
Harbeck, Nadia ;
Schmitt, Manfred ;
Eppenberger-Castori, Serenella ;
Vuaroqueaux, Vincent ;
Spyratos, Frederique ;
Foekens, John A. ;
Lesche, Ralf ;
Martens, John W. M. .
BMC CANCER, 2010, 10
[10]   Aberrant methylation of the maspin promoter is an early event in human breast cancer [J].
Futscher, BW ;
O'Meara, MM ;
Kim, CJ ;
Rennels, MA ;
Lu, D ;
Gruman, LM ;
Seftor, REB ;
Hendrix, MJC ;
Domann, FE .
NEOPLASIA, 2004, 6 (04) :380-389